Considerations for the Future of Rx-to-OTC Switches

David Spangler, J.D., Senior Vice President, Legal, Government Affairs & Policy, CHPA

Bernie Simone, Vice President of Client Strategy and Rx-to-OTC Switch, Pinney Associates

Clark Richardson, MPH, President & CEO, PEGUS Research, Inc.

Mary Alice Lawless, Founder and Chief Client Officer, Biograph Inc.

Francis E. Becker, M.D., FACP, Director, Division of Nonprescription Drugs II, Office of Nonprescription Drugs, U.S. Food and Drug Administration

Presented at CHPA Regulatory, Scientific & Quality Conference, September 9, 2021